Kuwait Cancer Diagnostics Market Size & Outlook, 2023-2030
Kuwait cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Kuwait cancer diagnostics market highlights
- The Kuwait cancer diagnostics market generated a revenue of USD 370.7 million in 2023 and is expected to reach USD 559.8 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer diagnostics market data book summary
| Market revenue in 2023 | USD 370.7 million |
| Market revenue in 2030 | USD 559.8 million |
| Growth rate | 6.1% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.3% of the global cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 609.1 million by 2030.
Consumables was the largest segment with a revenue share of 59.97% in 2023. Horizon Databook has segmented the Kuwait cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait is one of the fastest-growing countries in MENA due to its increasing exports and growing economy. With major advancements in its healthcare infrastructure, the country is addressing the growing prevalence of infectious, chronic, and lifestyle-associated diseases. Therefore, the rising prevalence of target diseases in the country is also a major factor driving the market.
Kuwait is increasingly emphasizing early diagnosis and screening for a better treatment outlook. Screening solutions have witnessed certain novel advancements, such as the adoption of advanced cancer diagnostic solutions and emphasis on precise diagnosis with increased usage of biomarkers.
The efforts of government & nongovernment organizations to raise patient awareness and facilitate early detection are fueling the demand for new cancer screening technologies. For instance, in October 2022, the National Campaign for Cancer Awareness launched a breast cancer awareness campaign in Kuwait. In addition, in December 2021, the Kuwait Cancer Control Center approved a cancer diagnostic service. This facility is concerned with novel diagnosis methods for breast cancer.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait cancer diagnostics market size, by product, 2018-2030 (US$M)
Kuwait Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
